These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 8213676

  • 1. Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy.
    Tyson D, Reggiardo D, Sklar C, David R.
    Am J Dis Child; 1993 Oct; 147(10):1057-61. PubMed ID: 8213676
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas.
    Tsagarakis S, Tsiganou E, Tzavara I, Nikolou H, Thalassinos N.
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):593-9. PubMed ID: 7634499
    [Abstract] [Full Text] [Related]

  • 3. Control of prolactin-secreting macroadenomas with parenteral, long-acting bromocriptine in 30 patients treated for up to 3 years.
    Haase R, Jaspers C, Schulte HM, Lancranja I, Pfingsten H, Orri-Fend M, Reinwein D, Benker G.
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):165-76. PubMed ID: 8435897
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Visual function improvement in patients with macroprolactinomas treated with bromocriptine.
    Lesser RL, Zheutlin JD, Boghen D, Odel JG, Robbins RJ.
    Am J Ophthalmol; 1990 May 15; 109(5):535-43. PubMed ID: 2333917
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Resistance to bromocriptine in prolactinomas.
    Pellegrini I, Rasolonjanahary R, Gunz G, Bertrand P, Delivet S, Jedynak CP, Kordon C, Peillon F, Jaquet P, Enjalbert A.
    J Clin Endocrinol Metab; 1989 Sep 15; 69(3):500-9. PubMed ID: 2760167
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hyperprolactinaemia in males: a heterogeneous disorder.
    Walsh JP, Pullan PT.
    Aust N Z J Med; 1997 Aug 15; 27(4):385-90. PubMed ID: 9448878
    [Abstract] [Full Text] [Related]

  • 11. Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy.
    Morange I, Barlier A, Pellegrini I, Brue T, Enjalbert A, Jaquet P.
    Eur J Endocrinol; 1996 Oct 15; 135(4):413-20. PubMed ID: 8921822
    [Abstract] [Full Text] [Related]

  • 12. Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.
    Shimon I, Sosa E, Mendoza V, Greenman Y, Tirosh A, Espinosa E, Popovic V, Glezer A, Bronstein MD, Mercado M.
    Pituitary; 2016 Aug 15; 19(4):429-36. PubMed ID: 27138902
    [Abstract] [Full Text] [Related]

  • 13. Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion.
    Wu ZB, Su ZP, Wu JS, Zheng WM, Zhuge QC, Zhong M.
    Pituitary; 2008 Aug 15; 11(1):63-70. PubMed ID: 17917811
    [Abstract] [Full Text] [Related]

  • 14. Combined bromocriptine and growth hormone (GH) treatment in GH-deficient children with macroprolactinoma in situ.
    Oberfield SE, Nino M, Riddick L, Pang S, Nagel M, Khandji A, Kairam R, Levine LS.
    J Clin Endocrinol Metab; 1992 Jul 15; 75(1):87-90. PubMed ID: 1619034
    [Abstract] [Full Text] [Related]

  • 15. Transsphenoidal surgery for pituitary gigantism and galactorrhea in a 3.5 year old child.
    Flitsch J, Lüdecke DK, Stahnke N, Wiebel J, Saeger W.
    Pituitary; 2000 May 15; 2(4):261-7. PubMed ID: 11081147
    [Abstract] [Full Text] [Related]

  • 16. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A, Finkel DM, Schatz NJ, Savino PJ, Snyder PJ.
    Ann Intern Med; 1984 Dec 15; 101(6):783-5. PubMed ID: 6497193
    [Abstract] [Full Text] [Related]

  • 17. DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine.
    Lloyd HM, Jacobi JM, Willgoss DA.
    Clin Endocrinol (Oxf); 1995 Jul 15; 43(1):79-85. PubMed ID: 7641414
    [Abstract] [Full Text] [Related]

  • 18. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
    Adler I, Barsi P, Czirják S, Varga I, Gergics P, Jakab C, Rácz K.
    Gynecol Endocrinol; 2005 Jun 15; 20(6):317-21. PubMed ID: 16019380
    [Abstract] [Full Text] [Related]

  • 19. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY, Jarrett JC, Choe JK.
    Fertil Steril; 1982 Oct 15; 38(4):415-8. PubMed ID: 6811337
    [Abstract] [Full Text] [Related]

  • 20. Large macroprolactinoma treated with bromocriptine alone.
    Loh KC, Shlossberg AH.
    Ann Acad Med Singap; 1996 Nov 15; 25(6):886-9. PubMed ID: 9055023
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.